ALGN
Align Technology, Inc. NASDAQ Listed Jan 30, 2001$168.32
Mkt Cap $12.1B
52w Low $122.00
53.7% of range
52w High $208.31
50d MA $178.34
200d MA $158.24
P/E (TTM)
31.6x
EV/EBITDA
13.5x
P/B
3.2x
Debt/Equity
0.0x
ROE
10.1%
P/FCF
23.1x
RSI (14)
—
ATR (14)
—
Beta
1.81
50d MA
$178.34
200d MA
$158.24
Avg Volume
1.3M
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
410 North Scottsdale Road · Tempe, AZ 85288 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | AMC | 2.26 | 2.58 | +14.2% | 178.40 | -0.8% | -1.3% | +1.6% | -3.9% | -1.8% | +3.1% | — |
| Feb 4, 2026 | AMC | 2.99 | 3.29 | +10.0% | 161.30 | +9.2% | +8.9% | +6.8% | +2.6% | +2.0% | +0.6% | — |
| Oct 29, 2025 | AMC | 2.40 | 2.61 | +8.8% | 131.91 | +10.1% | +4.9% | -0.4% | +0.5% | -2.1% | +1.1% | — |
| Jul 30, 2025 | AMC | 2.57 | 2.49 | -3.1% | 203.57 | -30.0% | -36.6% | +5.8% | +0.9% | +1.4% | -2.0% | — |
| Apr 30, 2025 | AMC | 1.99 | 2.13 | +7.0% | 173.30 | +9.6% | +2.0% | +1.7% | -1.2% | -2.6% | -0.5% | — |
| Feb 5, 2025 | AMC | 2.43 | 2.44 | +0.4% | 216.36 | +5.1% | +0.9% | -3.6% | +0.7% | -0.7% | -2.5% | — |
| Oct 23, 2024 | AMC | 2.31 | 2.35 | +1.7% | 207.66 | +3.3% | +4.2% | +1.3% | -1.6% | -1.4% | -0.9% | — |
| Jul 24, 2024 | AMC | 2.34 | 2.41 | +3.0% | 244.80 | -6.8% | -7.7% | -2.5% | +1.6% | +3.2% | +0.3% | — |
| Apr 24, 2024 | AMC | 1.97 | 2.14 | +8.6% | 313.78 | +3.6% | -1.0% | -0.5% | -1.4% | -7.4% | +0.8% | — |
| Jan 31, 2024 | AMC | 2.18 | 2.42 | +11.0% | 267.32 | +13.3% | +2.3% | +0.2% | +0.6% | +4.7% | -1.3% | — |
| Oct 25, 2023 | AMC | 2.26 | 2.14 | -5.3% | 253.69 | -22.4% | -24.9% | +0.2% | -2.2% | -1.2% | -0.7% | — |
| Jul 26, 2023 | AMC | 2.02 | 2.22 | +9.9% | 339.85 | +18.8% | +13.4% | -0.9% | -1.1% | -0.3% | -2.4% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 | Evercore ISI | Maintains | Outperform → Outperform | — | $178.40 | $177.00 | -0.8% | -1.3% | +1.6% | -3.9% | -1.8% | +3.1% |
| Apr 24 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $190.67 | $190.96 | +0.2% | -0.6% | -2.6% | -4.0% | +0.6% | -1.3% |
| Apr 21 | Piper Sandler | Maintains | Overweight → Overweight | — | $191.66 | $193.40 | +0.9% | +1.8% | +0.4% | -2.7% | -0.6% | -2.6% |
| Mar 17 | Barclays | Upgrade | Equal Weight → Overweight | — | $169.45 | $174.19 | +2.8% | +3.9% | -2.1% | +2.2% | -1.7% | +4.4% |
| Feb 26 | Barclays | Maintains | Equal Weight → Equal Weight | — | $188.05 | $188.53 | +0.3% | +0.6% | +0.5% | -0.6% | -3.4% | -0.3% |
| Feb 9 | HSBC | Upgrade | Hold → Buy | — | $187.60 | $188.00 | +0.2% | +2.6% | +2.0% | +0.6% | -6.9% | +1.6% |
| Feb 5 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $161.30 | $176.06 | +9.2% | +8.9% | +6.8% | +2.6% | +2.0% | +0.6% |
| Feb 5 | Wells Fargo | Maintains | Overweight → Overweight | — | $161.30 | $176.06 | +9.2% | +8.9% | +6.8% | +2.6% | +2.0% | +0.6% |
| Feb 5 | Piper Sandler | Maintains | Overweight → Overweight | — | $161.30 | $176.06 | +9.2% | +8.9% | +6.8% | +2.6% | +2.0% | +0.6% |
| Feb 5 | UBS | Maintains | Neutral → Neutral | — | $161.30 | $176.06 | +9.2% | +8.9% | +6.8% | +2.6% | +2.0% | +0.6% |
| Feb 5 | Stifel | Maintains | Buy → Buy | — | $161.30 | $176.06 | +9.2% | +8.9% | +6.8% | +2.6% | +2.0% | +0.6% |
| Feb 5 | Evercore ISI | Maintains | Outperform → Outperform | — | $161.30 | $176.06 | +9.2% | +8.9% | +6.8% | +2.6% | +2.0% | +0.6% |
| Jan 20 | Mizuho | Maintains | Outperform → Outperform | — | $171.49 | $167.28 | -2.5% | -3.5% | +2.7% | -0.6% | -0.1% | -0.6% |
| Oct 30 | Wells Fargo | Maintains | Overweight → Overweight | — | $131.91 | $145.22 | +10.1% | +4.9% | -0.4% | +0.5% | -2.1% | +1.1% |
| Oct 30 | Piper Sandler | Maintains | Overweight → Overweight | — | $131.91 | $145.22 | +10.1% | +4.9% | -0.4% | +0.5% | -2.1% | +1.1% |
| Oct 30 | Evercore ISI | Maintains | Outperform → Outperform | — | $131.91 | $145.22 | +10.1% | +4.9% | -0.4% | +0.5% | -2.1% | +1.1% |
| Oct 30 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $131.91 | $145.22 | +10.1% | +4.9% | -0.4% | +0.5% | -2.1% | +1.1% |
| Oct 21 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $134.93 | $133.62 | -1.0% | +1.0% | -0.5% | +0.3% | -0.6% | +0.3% |
| Oct 16 | UBS | Maintains | Neutral → Neutral | — | $128.43 | $129.14 | +0.6% | +1.1% | +0.5% | +3.4% | +1.0% | -0.5% |
| Oct 13 | Mizuho | Maintains | Outperform → Outperform | — | $125.79 | $127.25 | +1.2% | +3.0% | +0.2% | -1.0% | +1.1% | +0.5% |
| Oct 10 | Jefferies | Downgrade | Buy → Hold | — | $131.87 | $128.70 | -2.4% | -4.6% | +3.0% | +0.2% | -1.0% | +1.1% |
| Oct 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $130.47 | $130.56 | +0.1% | +2.0% | -0.9% | -4.6% | +3.0% | +0.2% |
| Jul 31 | Stifel | Maintains | Buy → Buy | — | $203.57 | $142.50 | -30.0% | -36.6% | +5.8% | +0.9% | +1.4% | -2.0% |
| Jul 31 | Piper Sandler | Maintains | Overweight → Overweight | — | $203.57 | $142.50 | -30.0% | -36.6% | +5.8% | +0.9% | +1.4% | -2.0% |
| Jul 31 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $203.57 | $142.50 | -30.0% | -36.6% | +5.8% | +0.9% | +1.4% | -2.0% |
| Jul 31 | Wells Fargo | Maintains | Overweight → Overweight | — | $203.57 | $142.50 | -30.0% | -36.6% | +5.8% | +0.9% | +1.4% | -2.0% |
| Jul 9 | Evercore ISI | Maintains | Outperform → Outperform | — | $195.47 | $197.05 | +0.8% | +2.6% | +2.0% | -1.1% | -1.5% | -3.3% |
| May 1 | Needham | Maintains | Hold → Hold | — | $173.30 | $190.00 | +9.6% | +2.0% | +1.7% | -1.2% | -2.6% | -0.5% |
| May 1 | Piper Sandler | Maintains | Overweight → Overweight | — | $173.30 | $190.00 | +9.6% | +2.0% | +1.7% | -1.2% | -2.6% | -0.5% |
| May 1 | Evercore ISI | Maintains | Outperform → Outperform | — | $173.30 | $190.00 | +9.6% | +2.0% | +1.7% | -1.2% | -2.6% | -0.5% |
| May 1 | Wells Fargo | Maintains | Overweight → Overweight | — | $173.30 | $190.00 | +9.6% | +2.0% | +1.7% | -1.2% | -2.6% | -0.5% |
| Apr 29 | Mizuho | Maintains | Outperform → Outperform | — | $181.09 | $181.56 | +0.3% | -1.8% | -2.5% | +2.0% | +1.7% | -1.2% |
| Apr 25 | HSBC | Downgrade | Buy → Hold | — | $184.27 | $181.51 | -1.5% | -0.5% | -1.2% | -1.8% | -2.5% | +2.0% |
| Apr 24 | UBS | Maintains | Neutral → Neutral | — | $177.23 | $178.16 | +0.5% | +4.0% | -0.5% | -1.2% | -1.8% | -2.5% |
| Apr 15 | Morgan Stanley | Maintains | Overweight → Overweight | — | $165.62 | $165.89 | +0.2% | -0.9% | +1.8% | +2.5% | +0.5% | +1.0% |
| Mar 25 | Mizuho | Maintains | Outperform → Outperform | — | $170.37 | $170.92 | +0.3% | -0.2% | -2.1% | -1.3% | -3.1% | -0.2% |
| Mar 18 | Piper Sandler | Maintains | Overweight → Overweight | — | $169.59 | $168.00 | -0.9% | -3.0% | +1.0% | +1.6% | -0.1% | +1.0% |
| Feb 6 | Needham | Maintains | Hold → Hold | — | $216.36 | $227.46 | +5.1% | +0.9% | -3.6% | +0.7% | -0.7% | -2.5% |
| Feb 6 | Evercore ISI | Maintains | Outperform → Outperform | — | $216.36 | $227.46 | +5.1% | +0.9% | -3.6% | +0.7% | -0.7% | -2.5% |
| Feb 6 | Piper Sandler | Maintains | Overweight → Overweight | — | $216.36 | $227.46 | +5.1% | +0.9% | -3.6% | +0.7% | -0.7% | -2.5% |
| Feb 6 | Morgan Stanley | Maintains | Overweight → Overweight | — | $216.36 | $227.46 | +5.1% | +0.9% | -3.6% | +0.7% | -0.7% | -2.5% |
| Jan 23 | Jefferies | Maintains | Buy → Buy | — | $232.14 | $231.63 | -0.2% | +1.2% | -0.7% | -1.5% | -1.6% | -0.8% |
| Jan 6 | Leerink Partners | Upgrade | Market Perform → Outperform | — | $208.26 | $215.31 | +3.4% | +5.1% | -0.6% | -1.0% | -1.5% | +0.7% |
| Dec 13 | BofA Securities | Maintains | Underperform → Underperform | — | $235.72 | $235.19 | -0.2% | -0.1% | -2.3% | -0.6% | -7.0% | +0.4% |
| Oct 24 | Baird | Maintains | Outperform → Outperform | — | $207.66 | $214.48 | +3.3% | +4.2% | +1.3% | -1.6% | -1.4% | -0.9% |
| Oct 24 | Piper Sandler | Maintains | Overweight → Overweight | — | $207.66 | $214.48 | +3.3% | +4.2% | +1.3% | -1.6% | -1.4% | -0.9% |
| Oct 24 | Stifel | Maintains | Buy → Buy | — | $207.66 | $214.48 | +3.3% | +4.2% | +1.3% | -1.6% | -1.4% | -0.9% |
| Oct 24 | Morgan Stanley | Maintains | Overweight → Overweight | — | $207.66 | $214.48 | +3.3% | +4.2% | +1.3% | -1.6% | -1.4% | -0.9% |
| Oct 24 | Evercore ISI | Maintains | Outperform → Outperform | — | $207.66 | $214.48 | +3.3% | +4.2% | +1.3% | -1.6% | -1.4% | -0.9% |
| Oct 17 | Piper Sandler | Maintains | Overweight → Overweight | — | $216.05 | $217.97 | +0.9% | -0.0% | +1.7% | -1.4% | -2.7% | -1.5% |
No insider trades available.
8-K · 5.03
! Medium
Align Technology Inc -- 8-K 5.03: Amendment to Articles / Bylaws
Align Technology (ALGN) changed its fiscal year-end, which may affect the timing of future financial reporting and earnings announcements for investors tracking the company's performance cycles.
Feb 26
8-K
Align Technology Inc -- 8-K Filing
Align Technology delivered strong Q4 2025 results with total revenues of $1.05 billion, up 5.3% year-over-year, driven by iTero Lumina upgrades and increased global demand across all business segments.
Feb 4
Data updated apr 24, 2026 5:14pm
· Source: massive.com